A membrane-based microfluidic device for controlling the flux of platelet agonists into flowing blood.

The flux of platelet agonists into flowing blood is a critical event in thrombosis and hemostasis. However, few in vitro methods exist for examining and controlling the role of platelet agonists on clot formation and stability under hemodynamic conditions. In this paper, we describe a membrane-based method for introducing a solute into flowing blood at a defined flux. The device consisted of a track-etched polycarbonate membrane reversibly sealed between two microfluidic channels; one channel contained blood flowing at a physiologically relevant shear rate, and the other channel contained the agonist(s). An analytical model described the solute flux as a function of the membrane permeability and transmembrane pressure. The model was validated using luciferase as a model solute for transmembrane pressures of 50-400 Pa. As a proof-of-concept, the weak platelet agonist ADP was introduced into whole blood flowing at 250 s(-1) at three fluxes (1.5, 2.4, and 4.4 x 10(-18) mol microm(-2) s(-1)). Platelet aggregation was monitored by fluorescence microscopy during the experiment and the morphology of aggregates was determined by post hoc confocal and electron microscopy. At the lowest flux (1.5 x 10(-18) mol microm(-2) s(-1)), we observed little to no aggregation. At the higher fluxes, we observed monolayer (2.4 x 10(-18) mol microm(-2) s(-1)) and multilayer (4.4 x 10(-18) mol microm(-2) s(-1)) aggregates of platelets and found that the platelet density within an aggregate increased with increasing ADP flux. We expect this device to be a useful tool in unraveling the role of platelet agonists on clot formation and stability.

[1]  J. Chang,et al.  Active sealing for soft polymer microchips: method and practical applications , 2006 .

[2]  M. Yovanovich,et al.  Pressure Drop of Fully-Developed, Laminar Flow in Microchannels of Arbitrary Cross-Section , 2006 .

[3]  Kevin Barraclough,et al.  I and i , 2001, BMJ : British Medical Journal.

[4]  L V McIntire,et al.  Mathematical analysis of mural thrombogenesis. Concentration profiles of platelet-activating agents and effects of viscous shear flow. , 1989, Biophysical journal.

[5]  M. Carr,et al.  Delayed, reduced or inhibited thrombin production reduces platelet contractile force and results in weaker clot formation , 2002, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[6]  W. Deen.  Hindered transport of large molecules in liquid‐filled pores , 1987 .

[7]  S. Kunapuli,et al.  Molecular mechanism of thromboxane A(2)-induced platelet aggregation. Essential role for p2t(ac) and alpha(2a) receptors. , 1999, The Journal of biological chemistry.

[8]  C. Legrand,et al.  Efficiency of platelet adhesion to fibrinogen depends on both cell activation and flow. , 2000, Biophysical journal.

[9]  A. Marcus,et al.  Thromboregulation: multicellular modulation of platelet reactivity in hemostasis and thrombosis , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  David J Beebe,et al.  Characterization of a membrane-based gradient generator for use in cell-signaling studies. , 2006, Lab on a chip.

[11]  Y. Nemerson,et al.  Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: real-time fluorescence images of thrombus formation and propagation under defined flow conditions. , 2002, Blood.

[12]  B. Furie,et al.  Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse , 2002, Nature Medicine.

[13]  G. Whitesides,et al.  Microfluidic arrays of fluid-fluid diffusional contacts as detection elements and combinatorial tools. , 2001, Analytical chemistry.

[14]  L V McIntire,et al.  Platelet active concentration profiles near growing thrombi. A mathematical consideration. , 1986, Biophysical journal.

[15]  Robert H. Davis,et al.  Membrane fouling during microfiltration of protein mixtures , 1996 .

[16]  M. Laffan,et al.  Thrombin generation and phenotypic correlation in haemophilia A , 2005, Haemophilia : the official journal of the World Federation of Hemophilia.

[17]  Ericka Stricklin-Parker,et al.  Ann , 2005 .

[18]  J. Merz,et al.  Laser-induced noninvasive vascular injury models in mice generate platelet- and coagulation-dependent thrombi. , 2001, The American journal of pathology.

[19]  R. Colman,et al.  Thrombosis and Haemostasis , 1988 .

[20]  S. Diamond,et al.  Selectin-like kinetics and biomechanics promote rapid platelet adhesion in flow: the GPIb/spl alpha/-vWF tether bond , 2002, Proceedings of the Second Joint 24th Annual Conference and the Annual Fall Meeting of the Biomedical Engineering Society] [Engineering in Medicine and Biology.

[21]  J. Moake,et al.  Platelet adhesion and aggregation on human type VI collagen surfaces under physiological flow conditions. , 1995, Blood.

[22]  J. Sixma,et al.  Platelet Adhesion to Collagen , 1995, Thrombosis and Haemostasis.

[23]  宁北芳,et al.  疟原虫var基因转换速率变化导致抗原变异[英]／Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .

[24]  M Wessling,et al.  Membranes and microfluidics: a review. , 2006, Lab on a chip.

[25]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[26]  James F. Antaki,et al.  Computational Simulation of Platelet Deposition and Activation: I. Model Development and Properties , 1999, Annals of Biomedical Engineering.

[27]  R. Stephenson.  A and V , 1962, The British journal of ophthalmology.

[28]  R. Rosenfeld.  Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[29]  M. Kahn.  Platelet-collagen responses: molecular basis and therapeutic promise. , 2004, Seminars in thrombosis and hemostasis.

[30]  E. Yong,et al.  Molecular basis of androgen receptor diseases , 2000, Annals of medicine.

[31]  A. Zydney,et al.  Effect of membrane morphology on the initial rate of protein fouling during microfiltration , 1999 .

[32]  Dana M Spence,et al.  Addressing a vascular endothelium array with blood components using underlying microfluidic channels. , 2007, Lab on a chip.

[33]  Robert H. Davis,et al.  Protein fouling of surface-modified polymeric microfiltration membranes , 1996 .

[34]  J. Hubbell,et al.  Local thrombin synthesis and fibrin formation in an in vitro thrombosis model result in platelet recruitment and thrombus stabilization on collagen in heparinized blood. , 1990, The Journal of laboratory and clinical medicine.

[35]  S L Diamond,et al.  Factor VIIa‐mediated tenase function on activated platelets under flow , 2004, Journal of thrombosis and haemostasis : JTH.

[36]  H. Goldsmith,et al.  Rheological Aspects of Thrombosis and Haemostasis: Basic Principles and Applications , 1986, Thrombosis and Haemostasis.

[37]  G. Whitesides,et al.  Rapid Prototyping of Microfluidic Systems in Poly(dimethylsiloxane). , 1998, Analytical chemistry.

[38]  Scott L. Diamond,et al.  Selectin-Like Kinetics and Biomechanics Promote Rapid Platelet Adhesion in Flow: The GPIbα-vWF Tether Bond , 2002 .

[39]  Robert H. Davis,et al.  Protein Fouling of Track-Etched Polycarbonate Microfiltration Membranes , 1994 .

[40]  Vicki Chen,et al.  Performance of partially permeable microfiltration membranes under low fouling conditions , 1998 .

[41]  S. Coughlin,et al.  Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis , 2007, Proceedings of the National Academy of Sciences.

[42]  S. Coughlin,et al.  Thrombin signalling and protease-activated receptors , 2000, Nature.

[43]  S. Diamond,et al.  Matrix protein microarrays for spatially and compositionally controlled microspot thrombosis under laminar flow. , 2006, Biophysical journal.

[44]  P. Sperryn,et al.  Blood. , 1989, British journal of sports medicine.